Slides and Webcasts from all ESMO Preceptorships are open to all ESMO account holders, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Virtual Preceptorship on Gastroenteropancreatic and Lung Neuroendocrine Neoplasms 2021
- Start date
- 21 Jun 2021
- End date
- 22 Jun 2021
- Location
- Virtual, CEST Time
Learning objectives
- Familiarise with the epidemiology, classification and prognostication of Gastroenteropancreatic (GEP) and Lung Neuroendocrine Neoplasms (NEN) patients
- Introduce principles of diagnostic and therapeutic strategy and the role of a multidisciplinary team
- Integrate different therapies in patients with advanced disease
- Update of new developments, clinical trials and unmet needs
Accreditation
The programme of this virtual event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Nicola Fazio, Italy
- Angela Lamarca, United Kingdom
Supported by
